5 Best Regional Bank Stocks To Buy Right Now

Large regional bank Synovus Financial (NYSE: SNV  ) has released its second-quarter earnings report, a week earlier�than previously stated. The report contained much good news for the troubled bank, but the early release was likely timed to coincide with an exciting announcement: The bank also revealed that it has a plan to finally repay its nearly $1 billion portion�of Troubled Asset Relief Program funds.

Lagging behind peers
Synovus isn't the only bank�that still has TARP money on its books, but it does owe the greatest amount. The financial crisis hit Synovus particularly hard, because it had a greater concentration of problematic commercial loans�on its balance sheet than bigger banks.

Megabanks�like Bank of America, Citigroup, and Wells Fargo, anxious to escape the additional scrutiny that accompanied bailout funds, received the green light in late 2009 to repay their own TARP debt. Fellow regional BB&T Corp. was able to repay its bailout money earlier that year, probably due to its unusually healthy�crisis-era balance sheet.

Hot Stocks To Watch Right Now: Dolan Co (DM)

The Dolan Company, incorporated in March 2003, is a provider of necessary professional services and business information to legal, financial and real estate sectors in the United States. The Company operates through two operating divisions: its Professional Services Division and its Business Information Division. Its Professional Services Division consists of two segments: mortgage default processing services and litigation support services. Its Business Information Division produces legal publications, business journals, court and commercial media, other online information products and services, and operates Websites and produces events for targeted professional audiences in 21 geographic markets across the United States. Its information is delivered through a variety of methods, including approximately 60 print publications and 80 Websites. The Company also operates specialized information services covering legislative and regulatory activities and providing transcription, media monitoring and translation services. On July 25, 2011, it acquired substantially all of the assets of ACT Litigation Services, Inc. (ACT). In July 2013, the Company sold the assets of its NDeX South business to the law firm affiliates of that business.

Professional Services

The Company�� Professional Services Division consists of two operating segments: mortgage default processing services and litigation support services. Its mortgage default processing services segment consists of the operations of NDeX. Its litigation support services segment consists of the operations of DiscoverReady, its discovery management and document review services business, and Counsel Press, its appellate services business. The Company provides these support services to the legal profession. In addition, NDeX also provides its services directly to mortgage lenders and loan servicers on California foreclosure files. One of the litigation support services it provides is discovery management and document review services, ! including certain technology services related to processing and hosting the data. Discovery is the process by which parties use the legal system to obtain relevant information, primarily in litigation, regulatory, and governmental investigation matters. Some United States companies with in-house legal departments choose to perform or manage some portions of the discovery process in-house, rather than outsourcing them.

The Company provides appellate services to lawyers in connection with both state and federal appeals. It performs more state appellate work, as state appellate case volume generally is larger than federal case volume. There are typically about 300,000 state appeals filed each year, compared to approximately 58,000 federal appeals filed per year, according to information available to the Company from the Administrative Office of the United States Courts and the National Center for State Courts. NDeX also provides real estate title services to the Barrett Law Firm and provides loan modification and loss mitigation support on mortgage default files to its customers. During the year ended December 31, 2011, it received approximately 317,200 mortgage default case files for processing from its customers.

In 2011, its mortgage default processing services segment accounted for 46% of its total revenues and 63% of its Professional Services Division�� total revenues. The Company�� litigation support services professionals at Counsel Press provide clients with consulting services, including procedural and technical advice and support with respect to the United States state and federal appellate processes. During 2011, its litigation support services segment accounted for 27% of its total revenues and 37% of its Professional Services Division�� total revenues. In addition to its appellate services, Counsel Press provides additional tracking and professional services to its clients.

Business Information

The Company provides business informatio! n product! s to companies and professionals in the legal, financial, real estate and governmental affairs sectors primarily through print and online business journals and court and commercial newspapers, as well as other electronic media offerings. Its business journals generally rely on display and classified advertising as a significant source of revenue and provide content that is relevant to the business communities they target. Its court and commercial newspapers generally rely on public notices as their primary source of revenue and offer information to the legal communities they target. All of its business journals and court and commercial newspapers also generate circulation revenue to supplement their advertising and public notice revenue base. There were more than 230 local business journals and more than 350 court and commercial newspapers nationwide, which generated approximately $2 billion in revenues in 2011.

The Company sells packaged print and online advertising products to advertisers that desire to reach readers through different media. Dolan Media Newswires, its Internet-based, subscription newswire, is available at www.dolanmedianewswires.com for news professionals and represents the work of its journalists and contributors. It also operates online, subscription-based legislative information services that are used by lobbyists, associations, corporations, unions, government affairs professionals, state agencies and the media in Arizona, Minnesota and Oklahoma. Through DataStream, it offers customized access to legislative databases, which provide state and federal legislative and regulatory information. Through Federal News, the Company offers transcription services.

The Company provides commercial printing services and sells database information through royalty or licensing fee arrangements. During2011, its subscription-based and other revenues accounted for 8% of its total revenues and 28% of its Business Information Division�� total revenues. The Company prints se! ven of it! s business information publications at one of its three printing facilities located in Baltimore, Minneapolis and Oklahoma City.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 stock that looks poised for a sharp move higher is Dolan (DM), a provider of necessary business information and professional services to the legal, financial and real estate sectors in the U.S. This stock has been hammered by the sellers so far in 2013, with shares off huge by 80%.

  If you take a look at the chart for Dolan Company, you'll notice that this stock has been downtrending badly over the last two months, with shares plunging lower from its high of $3 a share to its recent low of 66 cents per share. During that downtrend, shares of DM have been consistently making lower highs and lower lows, which is bearish technical price action. That move has now pushed shares of DM into oversold territory, since its current relative strength index reading is 20. Oversold can always get more oversold, but it's also an area where a stock can make a powerful bounce higher from.

  Market players should now look for long-biased trades in DM if it manages to break out above Thursday's high of 77 cents per share and then above some more near-term overhead resistance at 80 cents per share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 321,823 shares. If that breakout hits soon, then DM will set up for a possible powerful bounce higher that could easily take this stock back above $1 to $1.20 a share.

  Traders can look to buy DM off weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support levels at 71 cents to 66 cents per share. One can also buy DM off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Lisa Levin]

  The Dolan Company (NYSE: DM) shares fell 27.23% to reach a new 52-week low of $0.50 after the company received a continued listing standards notice from the NYSE and appointed Kevin Nystrom as Chief Restructuring Officer.

5 Best Regional Bank Stocks To Buy Right Now: Halozyme Therapeutics Inc.(HALO)

Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of recombinant human enzymes that transiently modify tissue under the skin to facilitate injection of other therapies or correct diseased tissue structures for clinical benefits. The company primarily offers recombinant human hyaluronidase, an enzyme that degrades hyaluronan, which is a matrix component in the skin, and facilitates the dispersion and absorption of drugs and fluids. Its portfolio of products and product candidates are developed based principally on intellectual property covering the family of human enzymes known as hyaluronidases. The company also provides Ultrafast Insulin program, a Phase II clinical trial product for the treatment of diabetes mellitus; and Enhanze technology, a proprietary drug delivery platform for subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as sma ll molecules and fluids. It offers PEGPH20, a new molecular entity that is in Phase I trial for the systemic treatment of tumors; and HTI-501, a recombinant human proteinase, which is in Phase 1/2 clinical trial used for the treatment of edematous fibrosclerotic panniculopathy (cellulite). The company has collaborative partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc.; ViroPharma Incorporated; and Intrexon Corporation to apply Enhanze technology to the partners? biological therapeutic compounds. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Advisors' Opinion:

• [By John Udovich]
  Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:

  ��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>

• [By Jayson Derrick]

  Halozyme Therapeutics (NASDAQ: HALO) halted patient enrollment and dosing in its Phase 2 clinical trial of PEGPH20 based on a recommendation by the Data Monitoring Committee who argued that there may be a difference in the thomboembolic rate between the PEGPH20 patients and the non-treated group. Shares lost 27.26 percent, closing at $8.43.

• [By Jake L'Ecuyer]

  Halozyme Therapeutics (NASDAQ: HALO) was also down, falling 13.11 percent to $13.91 after the company's wider than expected loss disappointed the street Friday morning.

• [By Bryan Murphy]

  Most of the time, for most stocks, the chart reflects a combination of trailing results and forward-looking prospects. Small biotech stocks, however, are a different beast altogether. They're almost entirely priced based on the potential of a particular drug or a small pipeline of drugs. This reality creates something of a challenge, as the perception of that potential can be wildly skewed by fear and greed. That's why trading biotech stocks is more about figuring out what the chart's trying to tell you, and figuring out when/where the trading crowd is going to flinch. Enter Halozyme Therapeutics, Inc. (NASDAQ:HALO). HALO has just turned technically "interesting" today, as the shape of the chart is suggesting a solid start to 2015 is in the cards.

5 Best Regional Bank Stocks To Buy Right Now: American Axle & Manufacturing Holdings Inc. (AXL)

American Axle & Manufacturing Holdings, Inc., together with its subsidiaries, engages in the manufacture, engineering, design, and validation of driveline and drivetrain systems, and related components and chassis modules for automotive industry in the United States. The company?s driveline and drivetrain systems comprise components that transfer power from the transmission and deliver it to the drive wheels. These products include axles, chassis modules, driveshafts, power transfer units, transfer cases, chassis and steering components, driving heads, crankshafts, transmission parts, and metal-formed products. It offers products for light trucks, sport utility vehicles, passenger cars, crossover vehicles, and commercial vehicles. The company was founded in 1994 and is headquartered in Detroit, Michigan.

Advisors' Opinion:

• [By Sue Chang]

  American Axle & Manufacturing Holdings Inc. (AXL) �is projected to report earnings of 56 cents a share in the third quarter.

• [By Ben Levisohn]

  Weekend news likely prompts a negative reaction Monday, but Tues-Wed could go either way. GM stock could respond well if March share meets/beats expectations and if GM were to make adequate statements explaining concerns and offering remedies (OnStar can play role here). A sub-17% share and/or more negative revelations could pressure the stock further. We enter the week with a buy-on-weakness approach but acknowledge that this latest escalation adds ST market share risk. Thus, we also look to add positions in Buy-rated Ford (F) (possible ST share gains) and [American Axle & Manufacturing (AXL)] (pulled back + Q2 schedules appear intact).

• [By Travis Hoium]

  What: Shares of American Axle & Manufacturing (NYSE: AXL  ) jumped as much as 13% after the company reported earnings.

  So what: First quarter revenue rose slightly, to $755.6 million, and net income was $7.3 million, or $0.23 per share after adjusting for debt refinancing costs. Consensus estimate was for $750 million in revenue, and earnings of $0.16 per share.�

• [By Seth Jayson]

  American Axle & Manufacturing Holdings (NYSE: AXL  ) is expected to report Q1 earnings on May 3. Here's what Wall Street wants to see:

5 Best Regional Bank Stocks To Buy Right Now: Tencent Holdings Ltd (TCEHY)

Tencent Holdings Limited is an investment holding company. The Company and its subsidiaries are principally engaged in the provision of Internet value-added services, mobile and telecommunications value-added services and online advertising services to users in the People�� Republic of China. The Company operates in four segments: Internet value-added services, Mobile and telecommunications value-added services, Online advertising, and Others. As of December 31, 2011, its subsidiaries included Tencent Cyber (Tianjin) Company Limited, Tencent Asset Management Limited, Tencent Technology (Beijing) Company Limited, Tencent Cyber (Shenzhen) Company Limited, Tencent Technology (Shanghai) Company Limited and others. Advisors' Opinion:

• [By Kevin Chen]

  In the video below, Fool contributor Kevin Chen details five reasons why SINA may be forever doomed:�

  SINA Weibo's daily active users may be exaggerated. Its registered users lag that of competitor Tencent� (NASDAQOTH: TCEHY  ) Weibo. Its penetration rate trails Tencent Weibo. Its geographic make-up isn't poised for China's economic growth. Meanwhile, Tencent Weibo is. Renren� (NYSE: RENN  ) , the "Facebook of China," and gaming portal�NetEase� (NASDAQ: NTES  ) threaten SINA Weibo's viability as a social network.�

  So before you try to profit from the growing microblogging market in China, watch the video below to learn more about the five things Wall Street overlooks when analyzing SINA.

• [By Victoria Zhang]

  Not all social networks are created equally
  Renren,�which operates one of the most popular�social networks in the second-largest economy, has lost more than 80% of its market capitalization�since it went public. To put this in perspective, in the same period, competitor Tencent Holdings� (NASDAQOTH: TCEHY  ) �experienced massive share appreciation, as its messaging apps�Tencent QQ and WeChat�gained international users, and therefore more advertisers. The company has become the third-largest Internet company in the world, only behind Google and Facebook.

• [By Damian Illia]

  The company has a current ratio of 11.8% which is higher than the one registered by Facebook (FB), InterXion Holding N.V. (INXN) and AOL Inc. (AOL). But for investors looking for a higher ROE, Tencent Holdings Ltd. (TCEHY) could be the option.